Glenwood Laboratories Canada Ltd.: Coping with Tariff War
In August 2018, Glenwood Laboratories Canada Ltd. (Glenwood), an importer of medical devices from the United States, is caught in the crossfire of public policy. In June 2018, the United States imposed a 10 per cent tariff on the import of raw aluminum from Canada; in July 2018, Canada imposed a retaliatory tariff of 10 per cent on the import of processed aluminum from the United States. As an importer of aluminum oxygen cylinders from the United States for distribution to its Canadian customers, Glenwood is in the middle of a trade war between the two countries, whose aluminum supply chains have been integrated for over two decades. Glenwood's president and chief executive officer (CEO) must examine the options before him and find a way forward.